<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Demographic screening disparities &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/demographic-screening-disparities/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Wed, 08 Oct 2025 23:16:49 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Demographic screening disparities &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Experts caution that prostate testing may miss targeting those who would benefit most</title>
		<link>https://bioengineer.org/experts-caution-that-prostate-testing-may-miss-targeting-those-who-would-benefit-most/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 08 Oct 2025 23:16:24 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Demographic screening disparities]]></category>
		<category><![CDATA[healthcare system burden]]></category>
		<category><![CDATA[Prostate cancer overtesting]]></category>
		<category><![CDATA[PSA retesting intervals]]></category>
		<category><![CDATA[PSA testing guidelines]]></category>
		<guid isPermaLink="false">https://bioengineer.org/experts-caution-that-prostate-testing-may-miss-targeting-those-who-would-benefit-most/</guid>

					<description><![CDATA[A new comprehensive study conducted in England has cast a critical spotlight on the current practices surrounding prostate specific antigen (PSA) testing, unveiling worrying trends of overtesting and misaligned testing intervals that could have profound implications for men’s health and healthcare systems. This landmark observational study, published in The BMJ, evaluated data from over 10 [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">277845</post-id>	</item>
	</channel>
</rss>
